|Articles|November 15, 2002

Caffeine Connection

Piscataway, N.J. - The topical application of caffeine or epigallocatechin gallate (EGCG) inhibited tumor formation in mice that were at high risk of skin cancer following a period of UVB irradiation in a laboratory study conducted at Rutgers University, New Jersey.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME